Wesana inks a multi-year research agreement with the World Boxing Council on psychedelics therapy for Traumatic Brain Injury (TBI).
Exploring the companies and themes that make up this emerging and exciting new sector
Numinus Wellness Announces Key Leadership Hires to Support Rapid Growth and Innovation
Numinus fills several key roles including a new Director of Mergers and Acquisitions and a new Chief Communications Officer.
COMPASS Pathways plc announces financial results and business highlights for the first quarter 2021
Compass Pathways highlights for Q1 include two new patents and reports its Phase IIb clinical trial is on track.
Molly, Psychedelic Drug, Shows Great Promise As Mental Health Treatment, New Study Finds
A couple hours after taking his first dose of the mind-altering drug 3,4-methylenedioxymethamphetamine, or MDMA, Bessel Van Der Kolk lay down on a couch in the presence of two psychotherapists, put on an eyeshade, and allowed himself to sink into a quiet, hypnotic state.
Wesana Health Commences Trading on the CSE
Wesana Health commences trading on the CSE, symbol "WESA".
The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same.
It’s been a long, strange trip in the four decades since Rick Doblin, a pioneering psychedelics researcher, dropped his first hit of acid in college and decided to dedicate his life to the healing powers of mind-altering compounds.
Psychedelic Stocks Slumber As Investors Sleep Through News
Lots of company news. Lots of industry news. Lots of new capital. But no investors. At the moment, they're busy GAMBLING.
Field Trip Health Ltd. Announces DTC Eligibility
Field Trip is now eligible for clearing and settlement through the DTC, boosting liquidity in the stock.
Texas House Approves Psychedelics Research Bill As Marijuana Reform Measures Also Advance
The Texas House of Representatives on Thursday approved to a bill that would require the state to conduct a study into the therapeutic potential of psychedelics like psilocybin and MDMA.
Why Smaller Psychedelics Companies Should Start Catching Up To The Sector Leaders
Psychedelic stocks have become extremely concentrated -- like other sectors. Here's why we see that changing in this sector.
MindMed Announces Project Angie, Targeting the Treatment of Pain with Psychedelics
MindMed commences "Project Angie": psychedelic drug R&D aimed at treating pain, involving psychedelics including LSD.
Small Pharma Inc. to Commence Trading on the TSX Venture Exchange on May 6, 2021
UK-based Small Pharma Inc will commence trading on the TSX Venture Exchange (via RTO) on May 6, 2021, under the symbol "DMT".